Opendata, web and dolomites

Predictix Antidepres

a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report with statistical analysis on the efficacy of antidepressants and their side effects

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Predictix Antidepres project word cloud

Explore the words cloud of the Predictix Antidepres project. It provides you a very rough idea of what is the project "Predictix Antidepres" about.

world    accessed    fairness    nervous    clinical    dr    patients    patient    noted    advantage    expertise    tool    revenue    care    organization    burden    framework    2012    measured    takes    worldwide    depression    practitioners    medicine    public    oren    personalized    financial    accurate    fastest    perfectly    technologies    vital    trade    medical    barriers    criteria    disability    house    dekel    plans    optimized    disease    personal    suffering    remission    ip    proprietary    adhd    central    machine    solution    fits    genetic    life    quality    anxiety    science    predictix    mission    decision    unfair    platform    international    health    services    finalisation    push    disorders    solutions    learning    efficiency    made    too    fast    recognizes    vision    economic    sequencing    genetics    sme    taliaz    date    receives    founded    prevalence    benefits    treatments    requested    standard    action    instrument    personalised    commercialisation    advancements    mental    data    ec    strategy    treatment   

Project "Predictix Antidepres" data sheet

The following table provides information about the project.

Coordinator
TALIAZ LTD 

Organization address
address: 2 PROF. YEHEZKEL KAUFMANN STREET TEXTILE CENTER, 15TH FLOOR
city: TEL-AVIV
postcode: 6801294
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.taliazhealth.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2019-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TALIAZ LTD IL (TEL-AVIV) coordinator 50˙000.00

Map

 Project objective

The World Health Organization recognizes mental disorders as one of the most significant public health challenges worldwide as measured by prevalence, burden of disease and disability , and depression as the world’s leading cause of disability. In EC and WHO action plans it is clearly requested that mental health services can be accessed without unfair financial barriers and that treatments are made available on criteria of both efficiency and financial fairness. In this framework personalised medicine is the fastest, most economic and optimized solution to the depression treatment problem. Indeed, the current push for a cost effective personalised medicine based on IT solution will also help with the commercialisation of our Predictix platform. The platform will allow medical practitioners to have up-to-date and accurate knowledge on each case and improve the care that patient receives, with an economic revenue too. Our solution allows for better delivery of available treatments – noted as a vital factor for increasing remission. TALIAZ was founded in 2012 by Dr. Dekel Taliaz and Oren Taliaz. Our mission is to set a new standard in personalized medicine improving quality of life for patients suffering from depression. Taliaz takes advantage of in-house expertise in genetics, data science and central nervous system related disease with the advancements in genetic sequencing and machine learning technologies, to develop leading personal medicine proprietary IP solutions for depression. Our future vision is to use Predictix™ also as a decision support tool for common health concerns such as ADHD and Anxiety. The SME Instrument project now perfectly fits our strategy and vision by enabling a fast finalisation of the platform development and by providing us the resources necessary to demonstrate the benefits of Predictix™ through an international clinical study.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICTIX ANTIDEPRES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICTIX ANTIDEPRES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More